NCT00432302 - Investigation of Mass Balance of the Test Drug and Major Metabolites | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Neoplasms

Interventions

DRUG

Sagopilone (BAY 86-5302, ZK 219477)

First infusion only: 28 mg, containing 14 kBq/7.8 mcg \[14C\]-ZK 219477. Subsequent infusions: 16 mg/m2 ZK 219477 without radioactive label. IV infusion was given over a period of 30 min.

Trial Locations (1)

4000

Liège